Search

Ulrich Berit O Bickel

from Amarillo, TX
Age ~66
Get Report
Also known as:
Ulrich Berit Bickel
Phone and address:
2313 Double Tree Pl, Amarillo, TX 79124
(806) 354-2784
Related to:
Jordis M Bickel, 22Berit Osburg BickelBerit Osburg, 53
Connected to:
Allison E Bickel, 38Andrea Bickel, 48Bernadette Bickel, 46Blair H Bickel, 68Bobby J Bickel, 59Charles D Bickel, 54Chris W Bickel, 44Curtis R Bickel, 71Dana L Bickel, 40Dawn M Bickel, 55

Ulrich Bickel Phones & Addresses

  • 2313 Double Tree Pl, Amarillo, TX 79124 (806) 354-2784
  • Loveland, CO
  • Oklahoma City, OK
  • Orlando, FL
  • Los Angeles, CA

Work

Company: Texas tech university health sciences center Nov 1999 Position: Professor

Industries

Higher Education

Resumes

Resumes

Ulrich Bickel Photo 1

Professor

View page
Location:
Amarillo, TX
Industry:
Higher Education
Work:
Texas Tech University Health Sciences Center
Professor

Business Records

Name / Title
Company / Classification
Phones & Addresses
Ulrich Bickel
Medical Doctor
Texas Tech Hsc
College/University
1300 S Coulter St, Amarillo, TX 79106

Publications

Us Patents

Encapsulation Of Nucleic Acids In Liposomes

View page
US Patent:
20080213350, Sep 4, 2008
Filed:
Feb 20, 2008
Appl. No.:
12/070602
Inventors:
Young Tag Ko - Boston MA, US
Ulrich Bickel - Amarillo TX, US
Assignee:
Texas Tech University System - Lubbock TX
International Classification:
A61K 9/127
US Classification:
424450
Abstract:
Complexes of nucleic acid and cationic polymer, which are encapsulated in liposomes for the purpose of delivering nucleic acid and methods for producing encapsulated complexes.

Tcr Mimic Antibodies As Vascular Targeting Tools

View page
US Patent:
20140134191, May 15, 2014
Filed:
Mar 23, 2012
Appl. No.:
14/007164
Inventors:
John A. Weidanz - Abilene TX, US
Ulrich Bickel - Amarillo TX, US
Assignee:
TEXAS TECH UNIVERSITY SYSTEM - Lubbock TX
International Classification:
A61K 39/395
US Classification:
4241781
Abstract:
The present invention includes a method of delivering a therapeutic agent into and across an endothelial cell (EC) in a subject in need thereof, comprising: attaching to a T Cell receptor mimic (TCR mimic) an active agent to form a therapeutic agent; and administering to the subject the therapeutic agent in a pharmaceutically acceptable carrier, wherein the therapeutic agent effectively crosses the EC microvascular barrier. Furthermore, the present invention relates to methods of treating diseases (particularly neuronal diseases) or conditions comprising identifying a subject in need of such a treatment and administering to said subject a composition comprising a TCR mimic conjugated to an active agent.

Tcr Mimic Antibodies As Vascular Targeting Tools

View page
US Patent:
20140134241, May 15, 2014
Filed:
Nov 12, 2013
Appl. No.:
14/078205
Inventors:
John A. Weidanz - Abilene TX, US
Ulrich Bickel - Amarillo TX, US
Assignee:
TEXAS TECH UNIVERSITY SYSTEM - Lubbock TX
International Classification:
C07K 16/28
US Classification:
424451, 4241341, 4241781
Abstract:
The present invention includes a method of delivering a therapeutic agent into and across an endothelial cell (EC) in a subject in need thereof, comprising: identifying a subject in need for treatment of a cancer in the brain; attaching to a TCR mimic an active agent to form a therapeutic agent; and administering to the subject the therapeutic agent in a pharmaceutically acceptable carrier, wherein the therapeutic agent effectively crosses the blood-central nervous system microvascular barrier.
Control profile
Ulrich Berit O Bickel from Amarillo, TX, age ~66 Get Report